nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A perspective on risks that impede development of drugs to modify the course of Alzheimer’s disease: Can they be reduced?
|
Mohs, Richard C. |
|
2008 |
|
1S1 |
p. S85-S87 3 p. |
artikel |
2 |
Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer’s disease
|
Poirier, Judes |
|
2008 |
|
1S1 |
p. S91-S97 7 p. |
artikel |
3 |
A quarter century of advancing treatment for Alzheimer’s disease with Leon J. Thal
|
Grundman, Michael |
|
2008 |
|
1S1 |
p. S51-S55 5 p. |
artikel |
4 |
Challenges in clinical research on Alzheimer’s disease: Leon Thal’s legacy
|
Petersen, Ronald C. |
|
2008 |
|
1S1 |
p. S88-S90 3 p. |
artikel |
5 |
Chronic disease long-term drug prevention trials: Lessons from the Alzheimer’s Disease Anti-inflammatory Prevention Trial (ADAPT)
|
Meinert, Curtis L. |
|
2008 |
|
1S1 |
p. S7-S14 8 p. |
artikel |
6 |
Contents
|
|
|
2008 |
|
1S1 |
p. A3- 1 p. |
artikel |
7 |
Contents
|
|
|
2008 |
|
1S1 |
p. A4- 1 p. |
artikel |
8 |
Current and future management of Alzheimer’s disease
|
Gauthier, Serge |
|
2008 |
|
1S1 |
p. S48-S50 3 p. |
artikel |
9 |
Current challenges for the successful treatment and prevention of Alzheimer’s disease: Treating the pathologies of the disease to change its clinical course
|
Schenk, Dale |
|
2008 |
|
1S1 |
p. S119-S121 3 p. |
artikel |
10 |
Dementia: Is it time for a change in focus?
|
Kuller, Lewis H. |
|
2008 |
|
1S1 |
p. S77-S84 8 p. |
artikel |
11 |
Differentiating Alzheimer’s disease from dementia with Lewy bodies and Parkinson’s disease with (+)-[11C]dihydrotetrabenazine positron emission tomography
|
Koeppe, Robert A. |
|
2008 |
|
1S1 |
p. S67-S76 10 p. |
artikel |
12 |
Disease-modifying approaches to Alzheimer’s disease: Challenges and opportunities—Lessons from donepezil therapy
|
Sabbagh, Marwan N. |
|
2008 |
|
1S1 |
p. S109-S118 10 p. |
artikel |
13 |
Drug discovery and the prevention of Alzheimer’s disease
|
Fillit, Howard |
|
2008 |
|
1S1 |
p. S26-S28 3 p. |
artikel |
14 |
Editorial board
|
|
|
2008 |
|
1S1 |
p. A5- 1 p. |
artikel |
15 |
Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer’s disease
|
Jackson, Colleen E. |
|
2008 |
|
1S1 |
p. S137-S143 7 p. |
artikel |
16 |
Eyes on the prize: Federal Alzheimer’s research effort aims to facilitate interventions
|
Hodes, Richard J. |
|
2008 |
|
1S1 |
p. S37-S47 11 p. |
artikel |
17 |
Home-based technologies: A new paradigm for conducting dementia prevention trials
|
Kaye, Jeffrey |
|
2008 |
|
1S1 |
p. S60-S66 7 p. |
artikel |
18 |
Leon Joel Thal, MD, 1944–2007: Honoring his scientific legacy
|
Khachaturian, Zaven S. |
|
2008 |
|
1S1 |
p. S1-S3 3 p. |
artikel |
19 |
Leon Thal and the therapeutic age of Alzheimer’s disease
|
Aisen, Paul S. |
|
2008 |
|
1S1 |
p. S4-S6 3 p. |
artikel |
20 |
Leon Thal’s vision for the treatment and prevention of Alzheimer’s disease
|
Weiner, Michael W. |
|
2008 |
|
1S1 |
p. S150-S152 3 p. |
artikel |
21 |
Medical and scientific advisory council
|
|
|
2008 |
|
1S1 |
p. A6- 1 p. |
artikel |
22 |
Memory health clinics—a first step to prevention
|
Vellas, Bruno |
|
2008 |
|
1S1 |
p. S144-S149 6 p. |
artikel |
23 |
More than a decade of estrogen neuroprotection
|
Simpkins, James W. |
|
2008 |
|
1S1 |
p. S131-S136 6 p. |
artikel |
24 |
Optimizing phase II of drug development for disease-modifying compounds
|
Cummings, Jeffrey L. |
|
2008 |
|
1S1 |
p. S15-S20 6 p. |
artikel |
25 |
Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses
|
Cansev, Mehmet |
|
2008 |
|
1S1 |
p. S153-S168 16 p. |
artikel |
26 |
Prevention therapeutics of dementia
|
Schneider, Lon S. |
|
2008 |
|
1S1 |
p. S122-S130 9 p. |
artikel |
27 |
Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer’s disease
|
Foster, Norman L. |
|
2008 |
|
1S1 |
p. S29-S36 8 p. |
artikel |
28 |
Subscriber information page
|
|
|
2008 |
|
1S1 |
p. A2- 1 p. |
artikel |
29 |
The oldest old and the 90+ Study
|
Kawas, Claudia H. |
|
2008 |
|
1S1 |
p. S56-S59 4 p. |
artikel |
30 |
The pre–mild cognitive impairment, subjective cognitive impairment stage of Alzheimer’s disease
|
Reisberg, Barry |
|
2008 |
|
1S1 |
p. S98-S108 11 p. |
artikel |
31 |
We should not distinguish between symptomatic and disease-modifying treatments in Alzheimer’s disease drug development
|
Doody, Rachelle S. |
|
2008 |
|
1S1 |
p. S21-S25 5 p. |
artikel |